Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity.

Recent advances in synthetic biology and biological system engineering have allowed the design and construction of engineered live biotherapeutics targeting a range of human clinical applications. In this review, we outline how systems approaches have been used to move from simple constitutive systems, where a single therapeutic molecule is expressed, to systems that incorporate sensing of the in vivo environment, feedback, computation, and biocontainment. We outline examples where each of these capabilities are achieved in different human disorders, including cancer, inflammation, and metabolic disease, in a number of environments, including the gastrointestinal tract, the liver, and the oral cavity. Throughout, we highlight the challenges of developing microbial therapeutics that are both sensitive and specific. Finally, we discuss how these systems are leading to the realization of engineered live biotherapeutics in the clinic.

[1]  Xavier Stien,et al.  Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity. , 2014, The Journal of clinical investigation.

[2]  Yoshinori Hamaji,et al.  Genetically engineered Bifidobacterium longum for tumor‐targeting enzyme‐prodrug therapy of autochthonous mammary tumors in rats , 2006, Cancer science.

[3]  Michael A. Fischbach,et al.  Synthetic Microbes As Drug Delivery Systems , 2014, ACS synthetic biology.

[4]  Chengzhe Tian,et al.  Programming a Pavlovian-like conditioning circuit in Escherichia coli , 2014, Nature Communications.

[5]  Chris P. Barnes,et al.  A Statistical Approach Reveals Designs for the Most Robust Stochastic Gene Oscillators , 2015, bioRxiv.

[6]  B. Weimer,et al.  Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens , 2013, Nature.

[7]  N. Forbes.  Engineering the perfect (bacterial) cancer therapy , 2010, Nature Reviews Cancer.

[8]  Faiza Hussain,et al.  Modular, Multi-Input Transcriptional Logic Gating with Orthogonal LacI/GalR Family Chimeras , 2014, ACS synthetic biology.

[9]  Thomas E. Landrain,et al.  De novo automated design of small RNA circuits for engineering synthetic riboregulation in living cells , 2012, Proceedings of the National Academy of Sciences.

[10]  Ivan Razinkov,et al.  Sensing array of radically coupled genetic biopixels , 2011, Nature.

[11]  B. Olle,et al.  Medicines from microbiota , 2013, Nature Biotechnology.

[12]  R. Ley,et al.  Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5 , 2010, Science.

[13]  Farren J. Isaacs,et al.  Recoded organisms engineered to depend on synthetic amino acids , 2015, Nature.

[14]  T. Shirakawa,et al.  Genetically modified Bifidobacterium displaying Salmonella-antigen protects mice from lethal challenge of Salmonella Typhimurium in a murine typhoid fever model. , 2010, Vaccine.

[15]  E. Zoetendal,et al.  Duodenal infusion of donor feces for recurrent Clostridium difficile. , 2013, The New England journal of medicine.

[16]  N. Paneth,et al.  A randomized synbiotic trial to prevent sepsis among infants in rural India , 2017, Nature.

[17]  Timothy K Lu,et al.  Programming a Human Commensal Bacterium, Bacteroides thetaiotaomicron, to Sense and Respond to Stimuli in the Murine Gut Microbiota. , 2016, Cell systems.

[18]  Yiannis N. Kaznessis,et al.  Modified Lactic Acid Bacteria Detect and Inhibit Multiresistant Enterococci , 2014, ACS synthetic biology.

[19]  R. Leer,et al.  Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C‐expressing lactobacilli , 2000, Immunology.

[20]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[21]  Dai Fukumura,et al.  Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors. , 2003, Cancer research.

[22]  John C March,et al.  Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model , 2010, Proceedings of the National Academy of Sciences.

[23]  James J Collins,et al.  “Deadman” and “Passcode” microbial kill switches for bacterial containment , 2015, Nature chemical biology.

[24]  Christoph Kaleta,et al.  Pervasive Selection for Cooperative Cross-Feeding in Bacterial Communities , 2016, PLoS Comput. Biol..

[25]  Jung-Joon Min,et al.  Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin , 2017, Science Translational Medicine.

[26]  J. Henker,et al.  The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers , 2007, European Journal of Pediatrics.

[27]  Christopher A. Voigt,et al.  Ribozyme-based insulator parts buffer synthetic circuits from genetic context , 2012, Nature Biotechnology.

[28]  G. Vinnicombe,et al.  Synchronous long-term oscillations in a synthetic gene circuit , 2016, Nature.

[29]  Jean Paul Remon,et al.  Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 , 2003, Nature Biotechnology.

[30]  A. Bast,et al.  Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. , 2009, Clinical nutrition.

[31]  Jeff Hasty,et al.  Programmable probiotics for detection of cancer in urine , 2015, Science Translational Medicine.

[32]  Timothy K. Lu,et al.  Synthetic mixed-signal computation in living cells , 2016, Nature Communications.

[33]  Jeff Hasty,et al.  Genetic Circuits in Salmonella typhimurium , 2012, ACS synthetic biology.

[34]  C. Hill,et al.  Next-generation probiotics: the spectrum from probiotics to live biotherapeutics , 2017, Nature Microbiology.

[35]  R. Langer,et al.  Advances in Drug Delivery , 1986 .

[36]  Tao Xi,et al.  Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection , 2016, Applied Microbiology and Biotechnology.

[37]  Audrey Lee-Gosselin,et al.  Tunable thermal bioswitches for in vivo control of microbial therapeutics. , 2017, Nature chemical biology.

[38]  M. Boyd,et al.  The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1 , 2002, AIDS.

[39]  P. Brun,et al.  Engineered E. coli delivers therapeutic genes to the colonic mucosa , 2005, Gene Therapy.

[40]  Wolf-Dietrich Hardt,et al.  Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae , 2012, Proceedings of the National Academy of Sciences.

[41]  Chris P. Barnes,et al.  A computational method for the investigation of multistable systems and its application to genetic switches , 2016, bioRxiv.

[42]  P. Swain,et al.  Mechanistic links between cellular trade-offs, gene expression, and growth , 2015, Proceedings of the National Academy of Sciences.

[43]  N. Cerf-Bensussan,et al.  The immune system and the gut microbiota: friends or foes? , 2010, Nature Reviews Immunology.

[44]  M. Omar Din,et al.  Synchronized cycles of bacterial lysis for in vivo delivery , 2016, Nature.

[45]  P. Brun,et al.  Engineered E. coli delivers therapeutic genes to the colonic mucosa , 2005, Gene Therapy.

[46]  Gürol M. Süel,et al.  Engineered E. coli that detect and respond to gut inflammation through nitric oxide sensing. , 2012, ACS synthetic biology.

[47]  X. Dray,et al.  A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. , 2008, Gastroenterologie clinique et biologique.

[48]  A. Singh,et al.  Pyrroloquinoline quinone-secreting probiotic Escherichia coli Nissle 1917 ameliorates ethanol-induced oxidative damage and hyperlipidemia in rats. , 2014, Alcoholism, clinical and experimental research.

[49]  Mauricio Barahona,et al.  Engineering modular and tunable genetic amplifiers for scaling transcriptional signals in cascaded gene networks , 2014, Nucleic acids research.

[50]  A. Maxmen.  Living therapeutics: Scientists genetically modify bacteria to deliver drugs , 2017, Nature Medicine.

[51]  J. Zhang,et al.  Targeting tumor gene by shRNA-expressing Salmonella-mediated RNAi , 2011, Gene Therapy.

[52]  D. Jonkers,et al.  Review article: the role of butyrate on colonic function , 2007, Alimentary pharmacology & therapeutics.

[53]  S. Park,et al.  Probiotics Therapeutic Implication Using Recombinant Human Intestinal Epithelial Cells : Epidermal Growth Factor Receptor in Escherichia coli Nissle 1917 via Human Enhanced Wound Healing by Recombinant , 2012 .

[54]  T. Lu,et al.  Synthetic recombinase-based state machines in living cells , 2016, Science.

[55]  M. Gillum,et al.  Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism , 2012, Proceedings of the National Academy of Sciences.

[56]  Sungha Park,et al.  Application of genetically engineered Salmonella typhimurium for interferon-gamma-induced therapy against melanoma. , 2017, European journal of cancer.

[57]  Michael Baym,et al.  Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation , 2017, Nature Biotechnology.

[58]  B. Niggemann,et al.  Linoleic Acid Metabolites and Transepidermal Water Loss in Children With Atopic Dermatitis , 2008, Pediatrics.

[59]  I. Rowland,et al.  Health benefits of probiotics: are mixtures more effective than single strains? , 2011, European journal of nutrition.

[60]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[61]  Christopher A. Voigt,et al.  Characterization of 582 natural and synthetic terminators and quantification of their design constraints , 2013, Nature Methods.

[62]  R. Morona,et al.  A recombinant probiotic for treatment and prevention of cholera. , 2006, Gastroenterology.

[63]  Christopher A. Voigt,et al.  Genetic circuit design automation , 2016, Science.

[64]  M. Bennett,et al.  A fast, robust, and tunable synthetic gene oscillator , 2008, Nature.

[65]  Jeff Hasty,et al.  Quorum Sensing Communication Modules for Microbial Consortia. , 2016, ACS synthetic biology.

[66]  Michael Zimmermann,et al.  Engineered Regulatory Systems Modulate Gene Expression of Human Commensals in the Gut , 2017, Cell.

[67]  C. Wei,et al.  Bifidobacteria Expressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice , 2016, Technology in cancer research & treatment.

[68]  Andrew D. Ellington,et al.  Directed evolution of genetic parts and circuits by compartmentalized partnered replication , 2013, Nature Biotechnology.

[69]  Timothy K Lu,et al.  Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases , 2014, Nature Biotechnology.

[70]  S. Prakash,et al.  Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial , 2012, European Journal of Clinical Nutrition.

[71]  Judy H. Cho,et al.  A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition. , 2016, Gastroenterology.

[72]  G. Church,et al.  Synthetic Gene Networks That Count , 2009, Science.

[73]  L. Hammarström,et al.  In situ delivery of passive immunity by lactobacilli producing single-chain antibodies , 2002, Nature Biotechnology.

[74]  Harris H. Wang,et al.  Multiplex recording of cellular events over time on CRISPR biological tape , 2017, Science.

[75]  Kinam Park,et al.  Analysis on the current status of targeted drug delivery to tumors. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[76]  Shuwen Yao,et al.  Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores. , 2015, Journal of medical microbiology.

[77]  Drew Endy,et al.  Precise and reliable gene expression via standard transcription and translation initiation elements , 2013, Nature Methods.

[78]  J. March,et al.  Engineered Commensal Bacteria Reprogram Intestinal Cells Into Glucose-Responsive Insulin-Secreting Cells for the Treatment of Diabetes , 2015, Diabetes.

[79]  Herbert M Sauro,et al.  Visualization of evolutionary stability dynamics and competitive fitness of Escherichia coli engineered with randomized multigene circuits. , 2013, ACS synthetic biology.

[80]  M. Anver,et al.  Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice. , 2014, Gastroenterology.

[81]  B. Murphy,et al.  Phase 1b, multicenter, single blinded, placebo‐controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy , 2013, Cancer.

[82]  L. Álvarez-Vallina,et al.  Programming Controlled Adhesion of E. coli to Target Surfaces, Cells, and Tumors with Synthetic Adhesins , 2014, ACS synthetic biology.

[83]  Chueh Loo Poh,et al.  Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen , 2011, Molecular systems biology.

[84]  Timothy K Lu,et al.  Synthetic circuits integrating logic and memory in living cells , 2013, Nature Biotechnology.

[85]  D. Laukens,et al.  Butyrate-producing bacteria supplemented in vitro to Crohn’s disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity , 2017, Scientific Reports.

[86]  G. Stan,et al.  Quantifying cellular capacity identifies gene expression designs with reduced burden , 2015, Nature Methods.

[87]  Franck Molina,et al.  Detection of pathological biomarkers in human clinical samples via amplifying genetic switches and logic gates , 2015, Science Translational Medicine.

[88]  Katherine H. Huang,et al.  Host genetic variation impacts microbiome composition across human body sites , 2015, Genome Biology.

[89]  Joseph H. Davis,et al.  Design, construction and characterization of a set of insulated bacterial promoters , 2010, Nucleic acids research.

[90]  G. N. Kumar,et al.  Genetically engineered Escherichia coli Nissle 1917 synbiotic counters fructose-induced metabolic syndrome and iron deficiency , 2017, Applied Microbiology and Biotechnology.

[91]  Chad W. Euler,et al.  Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials , 2014, Nature Biotechnology.

[92]  Jean Paul Thiery,et al.  Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention , 2018, Nature Biomedical Engineering.

[93]  L. Tsimring,et al.  A synchronized quorum of genetic clocks , 2009, Nature.

[94]  N. Lemoine,et al.  Potential therapeutic applications of recombinant, invasive E. coli , 2004, Gene Therapy.

[95]  Pauline Mayonove,et al.  A Modular Receptor Platform To Expand the Sensing Repertoire of Bacteria , 2017, ACS synthetic biology.

[96]  T. Lu,et al.  Genomically encoded analog memory with precise in vivo DNA writing in living cell populations , 2014, Science.

[97]  J. Collins,et al.  Complex cellular logic computation using ribocomputing devices , 2017, Nature.

[98]  E. Fikrig,et al.  Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis , 1995, Infection and immunity.

[99]  Richard A Fekete,et al.  Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[100]  S. Weiss,et al.  Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice. , 2009, Microbes and infection.

[101]  Jay D Keasling,et al.  Programming adaptive control to evolve increased metabolite production , 2013, Nature Communications.

[102]  Y. Kaznessis,et al.  pMPES: A Modular Peptide Expression System for the Delivery of Antimicrobial Peptides to the Site of Gastrointestinal Infections Using Probiotics , 2016, Pharmaceuticals.

[103]  Andrew E. Blanchard,et al.  An integrative circuit–host modelling framework for predicting synthetic gene network behaviours , 2017, Nature Microbiology.

[104]  Y. Chao,et al.  Metabolic engineering of Escherichia coli for production of butyric acid. , 2014, Journal of agricultural and food chemistry.

[105]  Wei Suong Teo,et al.  A Two-Layer Gene Circuit for Decoupling Cell Growth from Metabolite Production. , 2016, Cell systems.

[106]  Christopher A. Voigt,et al.  Robust multicellular computing using genetically encoded NOR gates and chemical ‘wires’ , 2011, Nature.

[107]  Tom Ellis,et al.  GeneGuard: A modular plasmid system designed for biosafety. , 2015, ACS synthetic biology.

[108]  M. Henn,et al.  A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection. , 2016, The Journal of infectious diseases.

[109]  Drew Endy,et al.  Amplifying Genetic Logic Gates , 2013, Science.

[110]  William E Bentley,et al.  Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models , 2017, Nature Communications.

[111]  Christophe Benoist,et al.  Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. , 2010, Immunity.

[112]  Chueh Loo Poh,et al.  Reprogramming microbes to be pathogen-seeking killers. , 2014, ACS synthetic biology.

[113]  Ryo Takeuchi,et al.  Biocontainment of genetically modified organisms by synthetic protein design , 2015, Nature.

[114]  Jeffrey J. Tabor,et al.  Engineering bacterial thiosulfate and tetrathionate sensors for detecting gut inflammation , 2017, Molecular systems biology.

[115]  Katherine H. Huang,et al.  Structure, Function and Diversity of the Healthy Human Microbiome , 2012, Nature.

[116]  P. Valet,et al.  Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota , 2011, Gut.

[117]  Hsiao‐Ling Chen,et al.  Probiotic Lactobacillus casei Expressing Human Lactoferrin Elevates Antibacterial Activity in the Gastrointestinal Tract , 2010, BioMetals.

[118]  Christopher A. Voigt,et al.  Environmentally controlled invasion of cancer cells by engineered bacteria. , 2006, Journal of molecular biology.

[119]  J. March,et al.  Secretion of Insulinotropic Proteins by Commensal Bacteria: Rewiring the Gut To Treat Diabetes , 2008, Applied and Environmental Microbiology.

[120]  R. Morona,et al.  Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea. , 2005, Gastroenterology.

[121]  Y. Kaznessis,et al.  Antimicrobial Probiotics Reduce Salmonella enterica in Turkey Gastrointestinal Tracts , 2017, Scientific Reports.

[122]  Shuanglin Xiang,et al.  Short hairpin RNA–expressing bacteria elicit RNA interference in mammals , 2006, Nature Biotechnology.

[123]  Irene Otero-Muras,et al.  Automated Design Framework for Synthetic Biology Exploiting Pareto Optimality. , 2017, ACS synthetic biology.

[124]  Andrew E. Blanchard,et al.  Engineering robust and tunable spatial structures with synthetic gene circuits , 2016, Nucleic acids research.

[125]  N. Forbes,et al.  Quorum-sensing Salmonella selectively trigger protein expression within tumors , 2015, Proceedings of the National Academy of Sciences.

[126]  W. Fiers,et al.  Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. , 2000, Science.

[127]  Kinam Park,et al.  Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[128]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[129]  Lei Yang,et al.  Permanent genetic memory with >1 byte capacity , 2014, Nature Methods.